We are live on ! Find out more
PAPAIJV

Paragon Associates & Paragon Associates II Joint Venture Portfolio holdings

AUM $73.6M
1-Year Est. Return 61.93%
This Fund
S&P 500
This Quarter Est. Return
+7.82%
1 Year Est. Return
+61.93%
3 Year Est. Return
+167.56%
5 Year Est. Return
+341.85%
10 Year Est. Return
+2,192.73%
AUM
$75.2M
AUM Growth
-$11.3M
Cap. Flow
-$15.9M
Cap. Flow %
-21.17%
Top 10 Hldgs %
93.84%
Holding
19
New
4
Increased
6
Reduced
3
Closed
3

Top Buys

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$2.53M
2
SD icon
SandRidge Energy
SD
+$1.76M
3
CF icon
CF Industries
CF
+$1.08M
4
NVGS icon
Navigator Holdings
NVGS
+$1.03M
5
AMPY icon
Amplify Energy
AMPY
+$1.03M

Top Sells

Rank Stock Value
1
BSFT
BroadSoft, Inc.
BSFT
+$7.69M
2
GDX icon
VanEck Gold Miners ETF
GDX
+$5.82M
3
FORM icon
FormFactor
FORM
+$5.21M
4
ESL
Esterline Technologies
ESL
+$3.04M
5
PARR icon
Par Pacific Holdings
PARR
+$924K

Sector Composition

Rank Sector Weight
1 Healthcare 35.92%
2 Energy 32.57%
3 Real Estate 11.76%
4 Materials 4.3%
5 Financials 1.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRIX icon
1
IRIDEX
IRIX
$15.1M
$17.6M 23.37%
1,250,000
– –
NVGS icon
2
Navigator Holdings
NVGS
$1.26B
$10.9M 14.53%
1,175,000
+125,000
+12% +$1.03M
PARR icon
3
Par Pacific Holdings
PARR
$3.9B
$10.7M 14.26%
737,568
-64,775
-8% -$924K
ESXB
4
DELISTED
Community Bankers Trust Corporation
ESXB
$7.93M 10.55%
1,094,000
+5,400
+0.5% +$32.4K
RETA
5
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$5.46M 7.26%
250,000
+100,000
+67% +$2.53M
AAT
6
American Assets Trust
AAT
$1.39B
$4.74M 6.3%
110,000
+916
+0.8% +$37.3K
HHH icon
7
Howard Hughes
HHH
$3.98B
$4.11M 5.46%
37,764
+6,294
+20% +$667K
CDNA icon
8
CareDx
CDNA
$2.45B
$3.98M 5.29%
1,473,800
– –
CF icon
9
CF Industries
CF
$18.2B
$3.15M 4.19%
100,000
+40,000
+67% +$1.08M
SD icon
10
SandRidge Energy
SD
$529M
$1.77M 2.35%
+75,000
New +$1.76M
AMPY icon
11
Amplify Energy
AMPY
$182M
$1.08M 1.44%
+52,100
New +$1.03M
BEN icon
12
Franklin Resources
BEN
$17.1B
$990K 1.32%
+25,000
New +$936K
BSFT
13
DELISTED
BroadSoft, Inc.
BSFT
$413K 0.55%
10,000
-180,000
-95% -$7.69M
ESIO
14
DELISTED
Electro Scientific Industries
ESIO
$296K 0.39%
50,000
-100,000
-67% -$547K
NGD
15
DELISTED
New Gold Inc
NGD
$88K 0.12%
+25,000
New +$94.9K
FORM icon
16
FormFactor
FORM
$10.1B
– –
-480,000
Closed -$5.21M
GDX icon
17
VanEck Gold Miners ETF
GDX
$27.8B
– –
-220,000
Closed -$5.82M
ESL
18
DELISTED
Esterline Technologies
ESL
– –
-40,000
Closed -$3.04M

Similar funds

TWM
Tripletail Wealth Management Orlando, Florida $73.4M AUM 26.64% 1-Year Est. Return
JCA
January Capital Advisors San Francisco, California $74.2M AUM
WH
Wallace Hart Lexington, Kentucky $72.6M AUM 34.63% 1-Year Est. Return
WPA
Winning Points Advisors Boca Raton, Florida $74.8M AUM
PWS
Pursuit Wealth Strategies Raleigh, North Carolina $72M AUM
SPC
Square Peg Capital Surry Hills, NSW, Australia $75.2M AUM 15.62% 1-Year Est. Return
OC
Owlhouse Capital New York $75.3M AUM
IVMX
Institutional Venture Management XV Menlo Park, California $75.5M AUM 16.43% 1-Year Est. Return

Paragon Associates & Paragon Associates II Joint Venture's Q4 2016 Portfolio in Review

As of Q4 2016, Paragon Associates & Paragon Associates II Joint Venture held 19 positions worth $75.2M, down 13% from $86.5M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Paragon Associates & Paragon Associates II Joint Venture withdrew a net $15.9M in Q4 2016, closing 3 positions and reducing 3 holdings. Its most notable exit was VanEck Gold Miners ETF, an estimated $5.82M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 32% a quarter earlier, followed by Energy and Real Estate.

Against the trend, Paragon Associates & Paragon Associates II Joint Venture opened a new position in SandRidge Energy worth $1.77M.

  • Paragon Associates & Paragon Associates II Joint Venture's largest Q4 2016 buy was SandRidge Energy: 75,000 shares worth $1.77M.
  • Paragon Associates & Paragon Associates II Joint Venture added most to Reata Pharmaceuticals, Inc. Class A Common Stock in Q4 2016, an estimated $2.53M increase.
  • Paragon Associates & Paragon Associates II Joint Venture's biggest Q4 2016 reduction was BroadSoft, Inc., cutting an estimated $7.69M.
  • Paragon Associates & Paragon Associates II Joint Venture fully exited VanEck Gold Miners ETF in Q4 2016, selling an estimated $5.82M.
  • Paragon Associates & Paragon Associates II Joint Venture's ten largest holdings make up 94% of its $75.2M portfolio in Q4 2016.
  • Paragon Associates & Paragon Associates II Joint Venture opened 4 new positions and closed 3 in Q4 2016.
  • Paragon Associates & Paragon Associates II Joint Venture's portfolio value fell 13% quarter-over-quarter to $75.2M.

Based on Paragon Associates & Paragon Associates II Joint Venture's 13F filing for Q4 2016, filed 13 Feb 2017.